Tumor-inhibiting Protein Could Be Effective In Treating Leukemia

Courtesy ScienceDaily  Tue, 07/15/2008 - 09:30

Angiocidin, a tumor-inhibiting novel protein, may also have a role as a new therapeutic application in treating leukemia by inducing a differentiation of monocytic leukemia cells into a normal, macrophage-like phenotype.


 

More related items

Potential New Way To Make A Good Anti-leukemia Drug...
A recently identified cancer-causing protein makes the anti-leukemia drug imatinib, less effective. By blocking the protein, researchers were able to slow the spread of leukemia cells in...

Methadone Breaks Resistance In Untreatable Forms Of...
Researchers have discovered that methadone, an agent used to break addiction to opioid drugs, has surprising killing power against leukemia cells, including treatment resistant forms of the...

New Hope For Multiple Sclerosis Sufferers
A drug which was initially designed to treat a form of leukemia has also proven effective against combating the debilitating neurological disease multiple sclerosis.

Vinegar: Over 400 Various, Versatile, and Very Good...
Vinegar is a health remedy, a neutralizer, a cleaner, a condiment, and a preservative. It can kill bacteria, mold, and germs, yet it is environmentally safe. This comprehensive guide covers...

The Complete Idiot's Guide to Chemistry, 2nd Edition...
Chemistry solutions that won’t get students all mixed up … With topics such as stoichiometry, chemical equilibria, and thermodynamics, it’s no wonder so many students have a bad...


 

Post new comment

The content of this field is kept private and will not be shown publicly.
science-nature.marc8.com